Purchase Order 75N93019P01049

Award Date 8/21/19
Potential Completion Date 9/30/19
Potential Value $28K
Ultimate Awardee
Qiagen N.V.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,500.00 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC. The contract is for an RT PCR System and does not have a set-aside designation. Qiagen, LLC is a subsidiary of the larger Qiagen N.V. corporation, an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has a history...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The $12,363.50 contract is for the provision of CARTRIDGE FOR QIASTAT-DX ANALYZER INSTRUMENT (AMBIS #2231080) with a period of performance through December 31, 2024. No set-aside designation was used for this award....
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $54,093.80 contract is for the provision of unspecified products and services, as there is no set-aside designation and no further description of the requirements. Qiagen is a long-standing federal contractor that has provided...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $4,094.11 firm-fixed-price purchase order to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. This award does not have a set-aside designation. The award supports Qiagen's provision of products and services to NIAID, such as DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and bioinformatics...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC for $28,440.75. The contract is for the QIAGEN QIAcube HT/QIAxtractor System, which are sample and assay technologies used to support federal agencies' biomedical research, public health, and healthcare programs. Qiagen, LLC is a subsidiary of the multinational biotechnology company...
Qiagen, LLC has been awarded a firm fixed price purchase order totaling $18,780.30 by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for an annual service agreement to provide support for Qiagen's QIAcuity Eight Digital PCR System in Bethesda, Maryland through February 27, 2025. No set-aside designation was used for this award to support the agency's research into allergies and infectious...
This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,348.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider Qiagen N.V. The service agreement, which does not have a set-aside designation, is for Qiagen's QIAGILLITY products and services. Qiagen is an experienced federal contractor, having provided a range of molecular diagnostics, biotechnology, and bioinformatics...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Qiagen, LLC for a QIAcuity Four Platform System, which is a digital PCR system. The contract was awarded on July 22, 2020 with a ceiling value of $110,846.00 and a completion date of July 22, 2021. The system includes a PCR instrument, laptop, software, and other accessories. The award was not set aside for any...

This $28,400 firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The agency procured the QIASTAT-DX ANALYZER, a real-time PCR system for detecting pathogen nucleic acids in human samples, with a completion date of September 30, 2019. No set-aside designations were used, and the award was made under a full and open brand name or equal solicitation that utilized simplified acquisition procedures. Qiagen has provided a range of products and services to support federal biomedical research, public health, and healthcare programs as a prime and subcontractor, including equipment, reagents, and bioinformatics software.

Generated 6/1/24, 10:15 AM